Trial · NCT00620542
Participant flow36
How many started, completed or left each group, period by period.
1 to 20 of 36
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Part A (Run-in - 2 Weeks) | STARTED | Rosuvastatin 20 mg | 1,167 | |
| Part A (Run-in - 2 Weeks) | STARTED | Atorvastatin 40 mg | 1,166 | |
| Part A (Run-in - 2 Weeks) | STARTED | Rosuvastatin 40 mg | 0 | |
| Part A (Run-in - 2 Weeks) | STARTED | Atorvastatin 80 mg | 0 | |
| Part A (Run-in - 2 Weeks) | Received Treatment | Rosuvastatin 20 mg | 783 | |
| Part A (Run-in - 2 Weeks) | Received Treatment | Atorvastatin 40 mg | 795 | |
| Part A (Run-in - 2 Weeks) | Received Treatment | Rosuvastatin 40 mg | 0 | |
| Part A (Run-in - 2 Weeks) | Received Treatment | Atorvastatin 80 mg | 0 | |
| Part A (Run-in - 2 Weeks) | COMPLETED | Rosuvastatin 20 mg | 695 | |
| Part A (Run-in - 2 Weeks) | COMPLETED | Atorvastatin 40 mg | 690 | |
| Part A (Run-in - 2 Weeks) | COMPLETED | Rosuvastatin 40 mg | 0 | |
| Part A (Run-in - 2 Weeks) | COMPLETED | Atorvastatin 80 mg | 0 | |
| Part A (Run-in - 2 Weeks) | NOT COMPLETED | Rosuvastatin 20 mg | 472 | |
| Part A (Run-in - 2 Weeks) | NOT COMPLETED | Atorvastatin 40 mg | 476 | |
| Part A (Run-in - 2 Weeks) | NOT COMPLETED | Rosuvastatin 40 mg | 0 | |
| Part A (Run-in - 2 Weeks) | NOT COMPLETED | Atorvastatin 80 mg | 0 | |
| Part B (2 Year Core Study) | STARTED | Rosuvastatin 20 mg | 0 | |
| Part B (2 Year Core Study) | STARTED | Atorvastatin 40 mg | 0 | |
| Part B (2 Year Core Study) | STARTED | Rosuvastatin 40 mg | 694 | |
| Part B (2 Year Core Study) | STARTED | Atorvastatin 80 mg | 691 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00620542/flow